Patrick P. Michel

13.5k total citations · 5 hit papers
142 papers, 10.7k citations indexed

About

Patrick P. Michel is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Patrick P. Michel has authored 142 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cellular and Molecular Neuroscience, 47 papers in Neurology and 38 papers in Molecular Biology. Recurrent topics in Patrick P. Michel's work include Parkinson's Disease Mechanisms and Treatments (44 papers), Nerve injury and regeneration (28 papers) and Neuroscience and Neuropharmacology Research (27 papers). Patrick P. Michel is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (44 papers), Nerve injury and regeneration (28 papers) and Neuroscience and Neuropharmacology Research (27 papers). Patrick P. Michel collaborates with scholars based in France, Brazil and United States. Patrick P. Michel's co-authors include Étienne C. Hirsch, Merle Ruberg, Yves Agid, Stéphane Hunot, Franz Hefti, Sheela Vyas, Bernard Brugg, Annick Mouatt‐Prigent, Baptiste Faucheux and Beat Knüsel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and The Journal of Experimental Medicine.

In The Last Decade

Patrick P. Michel

141 papers receiving 10.5k citations

Hit Papers

Apoptosis and autophagy in nigral neurons of patients wit... 1997 2026 2006 2016 1997 1999 2000 1997 2016 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    1997 862 citations Patrick P. Michel, Merle Ruberg et al. profile →
  2. CD8α+ and CD8α− Subclasses of Dendritic Cells Direct the Development of Distinct T Helper Cells In Vivo
    1999 821 citations Patrick P. Michel, Jacques Godfroid et al. profile →
  3. Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
    2000 591 citations Patrick P. Michel, Marie‐Paule Muriel et al. Proceedings of the National Academy of Sciences profile →
  4. Nuclear translocation of NF-κB is increased in dopaminergic neurons of patients with Parkinson disease
    1997 591 citations Patrick P. Michel, Marie‐Paule Muriel et al. Proceedings of the National Academy of Sciences profile →
  5. Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
    2016 444 citations Patrick P. Michel, Étienne C. Hirsch et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick P. Michel France 51 3.7k 3.7k 3.4k 1.6k 1.6k 142 10.7k
Malú G. Tansey United States 60 4.9k 1.3× 3.7k 1.0× 4.0k 1.2× 4.3k 2.6× 2.7k 1.7× 158 13.2k
Naren L. Banik United States 58 5.6k 1.5× 2.9k 0.8× 1.4k 0.4× 1.6k 1.0× 1.4k 0.9× 295 12.3k
Zheng‐Hong Qin China 62 6.5k 1.7× 2.8k 0.8× 1.7k 0.5× 1.9k 1.1× 1.6k 1.0× 252 12.6k
Li Gan United States 59 4.5k 1.2× 2.2k 0.6× 1.2k 0.4× 2.5k 1.5× 3.9k 2.5× 165 10.9k
Koichi Wakabayashi Japan 66 3.9k 1.0× 4.6k 1.2× 8.6k 2.5× 2.6k 1.6× 3.4k 2.1× 359 15.4k
Anthony Adame United States 59 3.1k 0.8× 2.8k 0.8× 3.2k 0.9× 2.4k 1.5× 3.6k 2.3× 110 9.4k
David Blum France 51 3.0k 0.8× 2.7k 0.7× 1.4k 0.4× 1.6k 1.0× 2.5k 1.6× 194 8.6k
Bin Liu United States 64 6.5k 1.7× 3.3k 0.9× 2.5k 0.8× 5.7k 3.5× 3.1k 2.0× 310 16.7k
Keiji Wada Japan 68 9.9k 2.6× 8.0k 2.2× 1.8k 0.5× 2.0k 1.2× 2.3k 1.4× 379 18.7k
Takeshi Tabira Japan 52 3.3k 0.9× 1.7k 0.5× 1.6k 0.5× 1.4k 0.9× 3.5k 2.2× 257 9.9k

Countries citing papers authored by Patrick P. Michel

Since Specialization
Citations

This map shows the geographic impact of Patrick P. Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick P. Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick P. Michel more than expected).

Fields of papers citing papers by Patrick P. Michel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick P. Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick P. Michel. The network helps show where Patrick P. Michel may publish in the future.

Co-authorship network of co-authors of Patrick P. Michel

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick P. Michel. A scholar is included among the top collaborators of Patrick P. Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick P. Michel. Patrick P. Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
González‐Lizárraga, Florencia, Susana Boluda, José Ruiz Hidalgo, et al.. (2025). Protein Coaggregation in Caribbean Atypical Parkinsonism: The Contribution of Annonacin. Neuropathology and Applied Neurobiology. 51(4). e70026–e70026.
2.
Fernandes, Telma, Maurício dos Santos Pereira, Jean Michel Brunel, et al.. (2025). Oxytetracycline and its Non-Antibiotic Derivative DOT Protect Midbrain Dopamine Neurons from Iron-Driven Oxidative Damage. Neurotoxicity Research. 43(2). 16–16. 1 indexed citations
3.
González‐Lizárraga, Florencia, Jean Michel Brunel, Rosana Chehı́n, et al.. (2025). Uric Acid, the End-Product of Purine Metabolism, Mitigates Tau-Related Abnormalities: Comparison with DOT, a Non-Antibiotic Oxytetracycline Derivative. Biomolecules. 15(7). 941–941. 1 indexed citations
4.
Pereira, Maurício dos Santos, Rita Raisman‐Vozari, Francisco Silveira Guimarães, et al.. (2024). 4′-fluorocannabidiol associated with capsazepine restrains L-DOPA-induced dyskinesia in hemiparkinsonian mice: Contribution of anti-inflammatory and anti-glutamatergic mechanisms. Neuropharmacology. 251. 109926–109926. 4 indexed citations
5.
Nascimento, Glauce Crivelaro, Laurent Ferrié, Bruno Figadère, et al.. (2024). Anti-nociceptive effects of non-antibiotic derivatives of demeclocycline and doxycycline against formalin-induced pain stimulation. European Journal of Pharmacology. 984. 177054–177054. 2 indexed citations
6.
Michel, Patrick P., Jean Michel Brunel, Rosana Chehı́n, et al.. (2024). C9‐Functionalized Doxycycline Analogs as Drug Candidates to Prevent Pathological α‐Synuclein Aggregation and Neuroinflammation in Parkinson's Disease Degeneration. ChemMedChem. 19(12). e202300597–e202300597. 2 indexed citations
7.
Villacé, Patricia, Clarisa Salado, Clémence Rose, et al.. (2023). NON-ANTIBIOTIC DOXYCYCLINE DERIVATIVE AGAINST Α-SYNUCLEIN AGGREGATION. IBRO Neuroscience Reports. 15. S507–S507. 1 indexed citations
8.
Boutin, Jean A., Elżbieta Janda, Florence Blandel, et al.. (2023). The specific NQO2 inhibitor, S29434, only marginally improves the survival of dopamine neurons in MPTP-intoxicated mice. Journal of Neural Transmission. 131(1). 1–11. 2 indexed citations
9.
Ferrié, Laurent, Stéphane Haı̈k, Patrick P. Michel, et al.. (2022). Effects of a New Natural Catechol-O-methyl Transferase Inhibitor on Two In Vivo Models of Parkinson’s Disease. ACS Chemical Neuroscience. 13(23). 3303–3313. 11 indexed citations
10.
González‐Lizárraga, Florencia, Diego Ploper, César L. Ávila, et al.. (2022). Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound. Cells. 11(17). 2759–2759. 6 indexed citations
11.
Ferrié, Laurent, Julia E. Sepúlveda-Díaz, Blandine Séon‐Méniel, et al.. (2017). Identification of a Novel 1,4,8-Triazaphenanthrene Derivative as a Neuroprotectant for Dopamine Neurons Vulnerable in Parkinson’s Disease. ACS Chemical Neuroscience. 8(6). 1222–1231. 4 indexed citations
12.
Desmazières, Anne, Jean Simonnet, Friederike Pfeiffer, et al.. (2015). Acceleration of conduction velocity linked to clustering of nodal components precedes myelination. Proceedings of the National Academy of Sciences. 112(3). E321–8. 55 indexed citations
13.
Michel, Patrick P., et al.. (2015). Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease. Experimental Neurology. 275. 209–219. 33 indexed citations
14.
Toulorge, Damien, Serge Guerreiro, Étienne C. Hirsch, & Patrick P. Michel. (2010). KATP channel blockade protects midbrain dopamine neurons by repressing a glia‐to‐neuron signaling cascade that ultimately disrupts mitochondrial calcium homeostasis. Journal of Neurochemistry. 114(2). 553–564. 23 indexed citations
15.
Guerreiro, Serge, Marc Marien, & Patrick P. Michel. (2010). Methylxanthines and Ryanodine Receptor Channels. Handbook of experimental pharmacology. 135–150. 15 indexed citations
16.
Guerreiro, Serge, Damien Toulorge, Elodie Martin, et al.. (2009). Protection of midbrain dopaminergic neurons by the end‐product of purine metabolism uric acid: potentiation by low‐level depolarization. Journal of Neurochemistry. 109(4). 1118–1128. 76 indexed citations
17.
Höllerhage, Matthias, Marie‐Paule Muriel, Pierre Champy, et al.. (2007). Annonacin, a Natural Mitochondrial Complex I Inhibitor, Causes Tau Pathology in Cultured Neurons. Journal of Neuroscience. 27(29). 7827–7837. 170 indexed citations
18.
Michel, Patrick P., Marc Marien, Merle Ruberg, Françis C. Colpaert, & Yves Agid. (1999). Adenosine Prevents the Death of Mesencephalic Dopaminergic Neurons by a Mechanism that Involves Astrocytes. Journal of Neurochemistry. 72(5). 2074–2082. 48 indexed citations
19.
Saegerman, Claude, Vincent Weynants, Liesbeth De Waele, et al.. (1994). Evaluation de l'activité protectrice de la fraction de la paroi de Brucella insoluble dans le SDS et identification d'antigènes de Brucella utilisables pour le diagnostic. Open Repository and Bibliography (University of Liège). 4 indexed citations
20.
Godfroid, Jacques, Patrick P. Michel, L. Uytterhaegen, et al.. (1994). Brucellose enzootique à Brucella suis biotype 2 chez le sanglier (sus scrofa) en Belgique. Open Repository and Bibliography (University of Liège). 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Malú G. Tansey Breakdown of academic impact, for papers by Naren L. Banik Breakdown of academic impact, for papers by Zheng‐Hong Qin Breakdown of academic impact, for papers by Li Gan Breakdown of academic impact, for papers by Koichi Wakabayashi Breakdown of academic impact, for papers by Anthony Adame Breakdown of academic impact, for papers by David Blum Breakdown of academic impact, for papers by Bin Liu Breakdown of academic impact, for papers by Keiji Wada Breakdown of academic impact, for papers by Takeshi Tabira
Rankless by CCL
2026